Mads Lamm Larsen
6PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 02, 2026
Real-world use of anifrolumab in systemic lupus erythematosus: A retrospective study from a Danish tertiary center (2022-2025).Laura Nørgaard, Mads Lamm Larsen, Bent Deleuran
|Sep 09, 2024
Dangers of Herpesvirus Infection in SLE Patients Under Anifrolumab Treatment: Case Reports and Clinical Implications.Mads Lamm Larsen, Morten Kelder Skouboe, Trine Hyrup Mogensen
|Jun 26, 2024
COVID-19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post-Pandemic Concerns About the Impact of Rituximab.Christian Ammitzbøll, Marianne Kragh Thomsen, Lars Erik Bartels
|Jul 05, 2023
Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosus.Mads Lamm Larsen, Anne Troldborg, Erik J M Toonen
|Feb 15, 2018
Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis.Mads Lamm Larsen, Oliver Heidmann Pedersen, Anne-Mette Hvas
Pageof 1
Frequent Collaborators
4 joint publications
Anne Troldborg
2 joint publications
Ellen-Margrethe Hauge
1 joint publications
A Voss
1 joint publications
C Tandrup Holst Nielsen
1 joint publications
Oliver Heidmann Pedersen
1 joint publications
Erik Lerkevang Grove
1 joint publications
Lisa Hurler
1 joint publications
Christian Ammitzbøll
1 joint publications
Marianne Kragh Thomsen
1 joint publications
Lars Erik Bartels
